Table 2 Mean levels of hormone measurements by group and according to menopausal status.
From: Low salivary testosterone levels in patients with breast cancer
| Â | Controls (sd) | Cases (sd) | p-value |
|---|---|---|---|
T | Â | Â | Â |
pre | 34.3 (16.1) | 31.4 (15.3) | 0.234 |
post | 31.0 (17.6) | 25.1(12.6) | 0.002 |
overall | 32.2 (17.5) | 27.2 (13.9) | < 0.001 |
E1 | Â | Â | Â |
pre | 3.8 (2.9) | 5.0 (2.9) | 0.037 |
post | 3.6 (2.1) | 4.8 (4.8) | 0.047 |
overall | 3.7 (2.4) | 4.9 (4.2) | 0.006 |
E2 | Â | Â | Â |
pre | 2.1 (2.1) | 2.4 (2.0) | 0.295 |
post | 1.2 (0.8) | 1.7 (1.3) | < 0.001 |
overall | 1.65 (1.3) | 2.0 (1.6) | 0.005 |
E3 | Â | Â | Â |
pre | 5.2 (7.3) | 2.7 (1.5) | 0.001 |
post | 3.7 (2.6) | 3.6 (3.8) | 0.734 |
overall | 4.3 (4.9) | 3.3 (3.3) | 0.011 |
DHEAS | Â | Â | Â |
pre | 7.3 (4.8) | 6.8 (4.9) | 0.434 |
post | 5.7 (4.2) | 4.5 (3.7) | 0.007 |
overall | 6.4 (4.5) | 5.3 (4.3) | 0.007 |
T/E1 | Â | Â | Â |
pre | 28.26 (46.7) | 8.23 (7.6) | < 0.001 |
post | 22.97 (79.5) | 8.74 (12.9) | 0.021 |
overall | 24.75 (68.5) | 8.57 (11.4) | 0.014 |
T/E2 | Â | Â | Â |
pre | 19.34 (11.6) | 19.90 (23.43) | 0.667 |
post | 34.09 (25.5) | 25.86 (52.3) | 0.063 |
overall | 27.45 (21.7) | 23.86 (44.6) | 0.212 |